Editors for Medicine
Senior editors
-
Olujimi A Ajijola
University of California, Los Angeles, United States
Dr Ajijola completed his undergraduate studies at the University of Virginia, and received his medical degree from Duke University. He went on to the Massachusetts General Hospital for residency training in internal medicine, and completed clinical fellowships in cardiovascular medicine and cardiac electrophysiology at UCLA. He received a PhD in Molecular, Cellular, and Integrative Physiology at UCLA, as part of the Specialty Training and Advanced Research (STAR) program. He is interested in novel approaches for cardiac arrhythmias, and performs invasive cardiac electrophysiological procedures. His research interests revolve around peripheral neural circuits that control cardiac function in health and disease, including neural interventions that alleviate progressive cardiac dysfunction and arrhythmias.
In addition to the NIH Director’s New Innovator award, he is a recipient of the Jeremiah Stamler Cardiovascular Research Award, an AP Giannini Foundation post-doctoral award, and a Young Physician Scientist Award from the American Society for Clinical Investigation (ASCI). He is a member of the New Voices program of the National Academies of Science, Engineering, and Medicine. He is a recipient of the Chan Zuckerberg Science Diversity Leadership Award and an elected member of the ASCI.
He is the Associate Director of the UCLA Cardiac Arrhythmia Center & EP Programs, and directs the Neurocardiology Research Program at UCLA. He also co-directs the NIH-funded UCLA-Caltech Medical Scientist Training Program.
- Expertise
- Medicine
- Research focus
- cardiovascular
- neurobiology
- sympathetic nerves
- ventricular arrhythmias
- RNA sequencing
- Competing interests statement
- Editorial roles: Journal of Electrocardiography, Heart Rhythm Journal 2019, Circulation: Arrhythmia & Electrophysiology, JACC Clinical Electrophysiology, Journal of the American Heart Association.PCT Patent Application No. PCT/US2022/015696Grants and fellowships: NIH/NHLBI, NIH SPARC, NIH/NIGMS, NIH/NHLB, Chan-Zuckerberg Initiative, Rethinking the Physician-Scientist Pipeline to Enhance Diversity, NIH/Case Western Reserve University
-
Matthias Barton
University of Zurich, Switzerland
Matthias Barton, MD, is a Professor of Cardiology at the University of Zurich. His clinical and investigative focus are general cardiology and preventive medicine, with a particular interest in coronary artery disease and myocardial infarction. His work explores mechanisms of atherosclerosis, heart disease in women, and vascular factors contributing to cardiovascular health and disease.
- Expertise
- Medicine
- Research focus
- cardiovascular medicine
- coronary artery disease
- vascular biology
- heart disease in women
- molecular medicine
- Competing interests statement
- Matthias Barton has received funding from the Swiss National Science Foundation and is on the editorial boards of the American Journal of Cardiovascular Disease, the American Journal of Physiology Regulatory Integrative & Comparative Physiology, Endocrine and Metabolic Science, Experimental Biology and Medicine, Arteriosclerosis, Thrombosis and Vascular Biology and Hypertension, official journals of the American Heart Association. He has been an elected ordinary member of the Academy of Europe (Academia Europaea) since 2017.
-
Balram Bhargava
Indian Council of Medical Research, India
Dr Bhargava is the Director General of the Indian Council of Medical Research (ICMR) Secretary, Department of Health Research, (Ministry of Health & Family Welfare), Government of India.
Professor (Dr) Balram Bhargava was born in Lucknow 21st July 1961. He received all his medical training at the King George Medical College, Lucknow. Further, he received advanced training at the Gardiner Institute, University of Glasgow and the Washington Heart Centre, Washington DC.
Balram Bhargava is Professor of Cardiology at the All India Institute of Medical Sciences, New Delhi, and also serves as the Executive Director for Stanford India Biodesign Centre, School of International Biodesign (SiB).
He is a cardiologist at the forefront of biomedical innovation, public health, medical education, and medical research. He directs the School of International Biodesign at AIIMS, an interdisciplinary programme to foster innovation and design of low-cost implants and devices which has led to more than thirty patents on low-cost medical devices and a dozen start-ups. He developed the indigenous Platinum Iridium coil coronary stent and has been instrumental in clinically evaluating and establishing medicated Indian stents. He has led innovations initiatives, such as Society for Less Investigative Medicine (SLIM). He is currently providing leadership for creative disease prevention, early detection, and transport system for sick cardiac patients (mission DELHI (Delhi Emergency Life Heart-Attack Initiative) by trained motorcycle first responder Paramedics).
Professor Bhargava was awarded the Padma Shri by the Indian government for his contributions to medicine. He is also been awarded the SN Bose Centenary Award by the Indian National Science Congress, the National Academy of Sciences Platinum Jubilee Award, the Tata Innovation Fellowship, Vasvik Award for Biomedical Technology Innovation, the Ranbaxy Award, OP Bhasin Award in the field of Health and Medical Sciences and more recently the UNESCO Equatorial Guinea Prize for Life Sciences. Dr Lee Jong-Wook Memorial Prize for Public Health, 2019 by WHO Hqrs, Geneva and received President’s Medal Award from Royal College of Physicians and Surgeons of Glasgow, UK for his research in ‘Frugal Innovations’ in February 2020.
- Expertise
- Medicine
- Epidemiology and Global Health
- Research focus
- interventional cardiology
- stents
- restenosis
- coronary artery disease
- risk factors of valvular heart disease
- interventions of rheumatic heart disease
- epidemiology
- non-communicable disease
- infectious disease
- health policy
- public health
- Experimental organism
- human
- Competing interests statement
- Dr Bhargava is the founding editor of the British Medical Journal Innovations (BMJi) until 2018, and he is currently the Editor-in-Chief of the Indian Journal of Medical Research.
-
Christian Büchel
University Medical Center Hamburg-Eppendorf, Germany
Christian Büchel is a member of the Hamburg Center for Neuroscience in Hamburg, where he is also the Director of the Department for Systems Neuroscience at Hamburg University Medical Center. He holds an Affiliate Professor appointment in the Psychology department at the University of Hamburg. After Medical School at the University of Heidelberg, he performed postdoctoral research with Karl Friston as a Wellcome Research Fellow at the Wellcome Department of Imaging Neuroscience at UCL in London with a focus on effective connectivity.
Establishing his lab in Hamburg, he focused on the cognitive neuroscience of pain and motivation and initially studied decision making with an emphasis on delay discounting. In a parallel stream of projects he observed that the pain modulation underlying placebo analgesia can already be observed at the spinal cord level, a finding which he later also established for nocebo hyperalgesia. He is part of the IMAGEN study and during his time at Stanford he identified hypoactivation of reward circuits as a potential risk factor for addiction.
He is a member of the Academy of Science in Hamburg and was awarded the Jung Award for Medicine, the Gottfried Wilhelm Leibniz-Preis by the German Research Foundation, and the Wiley Young Investigator Award of the Organization for Human Brain Mapping for recognition of his work in cognitive neuroscience.
- Expertise
- Neuroscience
- Medicine
- Research focus
- cognitive neuroscience
- pain modulation
- decision-making
- fear
- anxiety
- addiction
- Experimental organism
- human
- Competing interests statement
- Christian Büchel has received research grants from the European Research Council, Deutsche Forschungsgemeinschaft and Bundesministerium für Bildung und Forschung. He serves on the board of reviewing editors of Science magazine. He serves on the Swiss National Research Council, the Scientific Advisory Board of the ICM in Paris and the Center for Behavioral Brain Sciences, Magdeburg, Germany.
-
Murim Choi
Seoul National University College of Medicine, South Korea
Murim Choi’s main scientific question is to elucidate the genetic mechanisms of human diseases. To address this, his expertise lies in the functional interpretation of human genetic variants using genomic and bioinformatic methodologies. He graduated from Seoul National University (SNU), Seoul, Korea, majoring in Molecular Biology (BS and MS). During the Ph.D course at Duke University, he studied cardiovascular system development in mice. In his postdoctoral training at Yale University, he studied human genetics, setting up a whole exome sequencing pipeline and applying it to various human diseases to identify causal genes. He received a K99/R00 grant for the postdoctoral works and was a recipient of SNU Invitation Program for Distinguished Scholar grant.
Establishing his independent lab at SNU, he has been studying the genetic mechanisms of rare disease pathogenesis, focusing on cases with neurodevelopmental defects. His current approach combines developmental biology and genetics, shaped by the fact that most pediatric rare disease patients experience congenital problems. More recently, his group has undertaken common disease research. His group recently established a bioinformatic pipeline that allows screening of eQTL signals only functioning in the non-alcoholic fatty liver disease (NAFLD) status and validated its utility. At SNU, he has been instrumental in establishing genetics and genomics methodologies by collaborating with clinicians in SNU Hospital. His lab has recently established protocols in advanced functional genomics approaches, including single-cell sequencing, saturation mutagenesis, modifier screening, and cell tracing technique to understand the genetic mechanisms underlying disease progression.
He has a strong interest in clinical and translational research, especially in elucidating genotype-phenotype relationships that may lead to human diseases. In 2018, he was selected as a member of the Young Korean Academy of Science and Technology.
- Expertise
- Genetics and Genomics
- Medicine
- Research focus
- rare diseases
- neurodevelopmental disorders
- functional characterization of genetic variants
- bioinformatics
- Mendelian genetics
- Competing interests statement
- Current funding: Genetic elucidation of rare developmental disorders (200M KRW/year (~152,800 USD); Apr. 2014-Sep.2022; National Research Foundation of Ministry of Science and ICT); Genetic elucidation of gene expression noises (300M KRW/year (~229,200 USD); Mar. 2021-Feb. 2025; National Research Foundation of Ministry of Science and ICT); Discovery of NAFLD causing genes using single cell expression quantitative trait loci approach (80M KRW/year (~61,120 USD); Apr. 2021-Dec. 2025; National Research Foundation of Ministry of Science and ICT).Other editorial roles: editor of Experimental and Molecular Medicine (Springer Nature)
-
Betty Diamond
The Feinstein Institute for Medical Research, United States
Betty Diamond received an MD from Harvard Medical School. She performed a residency in Internal Medicine at Columbia Presbyterian Medical Center, and then a post-doctoral fellowship in Immunology with Dr Matthew Scharff at the Albert Einstein College of Medicine. She is currently Director of the Institute of Molecular Medicine at the Feinstein Institute for Medical Research.
Dr Diamond’s research has focused on the induction and pathogenicity of anti-DNA antibodies in Systemic Lupus Erythematosus. She showed that somatic mutation of immunoglobulin genes can generate autoantibodies in mice and humans, making the germinal center a focus in disease pathogenesis. Her laboratory has also demonstrated that a subset of anti-DNA antibodies cross-reacts with the NMDA receptor and showed that autoantibodies can cause aspects of neuropsychiatric lupus, creating a paradigm for antibody-mediated changes in brain function in many conditions. Most recently, she has developed a research program on the immunomodulatory functions of C1q.
She received the Outstanding Investigator Award of the ACR in 2001, the Lee Howley Award from the Arthritis Foundation in 2002, and the Recognition Award from the National Association of MD-PhD Programs in 2004 and the AAI Distinguished Fellow Award in 2019. In 2006, she was elected to the Institute of Medicine and became a fellow of the AAAS. She has served on the Scientific Council of NIAMS and the Board of Directors of the American College of Rheumatology. She is a past President of the American Association of Immunologists.
- Expertise
- Medicine
- Immunology and Inflammation
- Research focus
- B cells
- systemic lupus
- neuropsychiatric lupus
- autoantibodies
- autoimmunity
- Experimental organism
- human
- mouse
- Competing interests statement
- Betty Diamond receives funding from the NIH, LuCIN (Lupus Clinical Investigators Network), Lupus Research Alliance, DOD Lupus and Leidos Biomedical Research, Inc.. She is the Chief Editor at Molecular Medicine and a Deputy Editor for Frontiers in Immunology.
-
Wafik S El-Deiry
Brown University, United States
Wafik El-Deiry, MD, PhD, FACP is Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, Director, Cancer Center at Brown University, and Director of the Joint Program in Cancer Biology at Brown and Lifespan. He is a Professor of Pathology and Laboratory Medicine, Professor of Medical Science, and Mencoff Family University Professor at Brown. He sees patients in his weekly clinic at Rhode Island Hospital focused on care of patients with colorectal cancer and participates in clinical trials based on his laboratory’s research on novel therapeutics. He previously served as Deputy Director for Translational Research, co-Leader of the Molecular Therapeutics Program, Professor of Oncology, and the William Wikoff Smith Endowed Chair in Cancer Research at Fox Chase Cancer Center. From 2010 through 2014 Dr El-Deiry was the Rose Dunlap Professor of Medicine and Chief of Hematology-Oncology at Penn State. In 2009, El-Deiry became an American Cancer Society Research Professor. He was previously a tenured Professor of Medicine (Hematology-Oncology), Genetics, and Pharmacology at University of Pennsylvania, co-Leader of the Radiobiology and Imaging Program at the Abramson Cancer Center and Associate Director for Physician-Scientist Training in Hematology-Oncology when he left Penn in 2010. He earned MD/PhD degrees from University of Miami School of Medicine and completed internal medicine residency and medical oncology fellowship at the Johns Hopkins Hospital and the Johns Hopkins Oncology Center. As a practicing academic Oncologist, his scientific interest and expertise is in cell death, drug resistance in cancer and drug discovery and development. El-Deiry founded two companies, Oncoceutics, Inc. and p53-Therapeutics, Inc.
El-Deiry discovered p21(WAF1) as a p53 target gene, universal cell cycle inhibitor, and tumor suppressor gene that for the first time explained the mammalian cell stress response. He discovered TRAIL receptor DR5 and its regulation by p53. TRAIL is part of the host immune system that suppresses cancer and its metastases. His lab created a knock-out mouse for TRAIL receptor DR5 and this mouse is tumor prone and develops an inflammatory syndrome in the lungs and gut after sub-lethal irradiation. He identified c-Myc as a major determinant of TRAIL sensitivity and demonstrated synergy between TRAIL therapy and multi-kinase inhibitor sorafenib. Building on his prior accomplishments, El-Deiry discovered ONC201/TIC10 as a first-in-class TRAIL pathway inducer that is orally bioavailable and crosses the blood-brain barrier to treat brain tumors. TRAIL and Foxo3a are required for the anti-tumor effect of ONC201 through dual blockade of ERK and Akt kinases that promotes the nuclear translocation of the Foxo3a transcription factor which directly regulates the TRAIL gene. Data from El-Deiry’s lab identified that ONC201 induces TRAIL receptor DR5 through an integrated stress response involving ATF4 and CHOP transcription factors. Patients with among the most aggressive gliomas (H3K27M mutant DIPG) have had exceptional responses to ONC201.
As a physician-scientist, Dr El-Deiry has worked to bring new discoveries to the clinic. He is committed in the next phase of his career to unraveling the mechanisms involved in p53 pathway restoration by candidate therapeutics his lab has discovered. This is exciting as he is defining a novel class of anti-cancer drugs with p53 pathway restoration and S-phase checkpoint targeting and recognizing ATF4 as a major transcription factor mechanism for p53 pathway restoration in p53-null or p53 mutant tumor cells. He is establishing transcriptomic and proteomic data sets with chemotherapy that acts through p53, and with novel small molecules that restore the p53 pathway in p53-deficient or mutant p53 expressing cells. He is exploiting medicinal chemistry and organoid technologies to perform his translational science that is leading to clinical trials some of which he leads. Dr El-Deiry conducts basic and translational clinical oncology therapeutics research through funded NIH grants, Foundations and industry. He is a member of the ASCI, AAP, Past President of the Interurban Clinical Club, previous Chair of ASCO’s Tumor Biology Track, and past Chair of an NIH Study Section on Cancer Therapeutics. Dr El-Deiry has trained many students and post-doctoral fellows, physician-scientists, and continues to mentor junior scientists and faculty in basic and translational cancer research.
- Expertise
- Medicine
- Cancer Biology
- Research focus
- cancer
- tumor suppressor genes
- colorectal cancer
- p53 pathway
- cell death
- medical oncology
- drug development
- drug discovery
- p21(WAF1)
- ONC201/TIC10
- physician-scientist issues
- Experimental organism
- human
- mouse
- Competing interests statement
- Dr El-Deiry receives funding from the NIH/NCI, the Warren Alpert Foundation, and D&D Pharmatech. He is a Specialty Chief Editor for the Cancer Molecular Targets and Therapeutics Section of Frontiers in Oncology. He is also a Section Editor for Molecular Oncology and HemOnc Today. Dr El-Deiry is the scientific founder and shareholder of Oncoceutics, Inc. and p53-Therapeutics, Inc.
-
Eduardo Franco
McGill University, Canada
Eduardo Franco is Professor and Chairman, Department of Oncology, and Director, Division of Cancer Epidemiology, McGill University, Montreal. He holds BSc (1975) and Licentiate (1976) degrees in biology from Universidade de Campinas, Brazil, and master's (MPH) and doctoral (DrPH) degrees in public health microbiology from the University of North Carolina at Chapel Hill (1981-84). He was a Guest Researcher at the US Centers for Disease Control in Atlanta (1980-81 and 1983-84), and a post-doctoral fellow in cancer epidemiology during 1984 at the International Agency for Research on Cancer in Lyon, France, at the US National Cancer Institute (NCI) in Bethesda, and at Louisiana State University, in New Orleans. Since 1985, he has conducted epidemiologic research on the causes of cancer and on the means to prevent it or to improve patient survival. He is mostly known for his contributions to our understanding of human papillomavirus infection as the cause of cervical cancer and using this knowledge to prevent this cancer via vaccination and improved screening strategies. He received the Canadian Cancer Research Alliance’s Distinguished Service to Cancer Research Award, Lifetime Achievement Awards from the American Society for Colposcopy and Cervical Pathology and from the International Papillomavirus Society, the Women in US Government’s Leadership Award, the Canadian Cancer Society’s Warwick Prize, the Geoffrey Howe Outstanding Contribution Award from the Canadian Society for Epidemiology and Biostatistics, the University of British Columbia’s Chew Wei Memorial Prize in Cancer Research, and the McLaughlin-Gallie Award from the Royal College of Physicians of Canada. He has mentored 115 graduate students and post-doctoral fellows, and 30 undergraduate trainees. He is Officer of the Order of Canada and Fellow of the Royal Society of Canada and of the Canadian Academy of Health Sciences. Heholds an honorary doctorate from Universidade Fernando Pessoa, Porto, Portugal.
- Expertise
- Cancer Biology
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer epidemiology
- cancer prevention
- human papillomavirus
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Entire research program funded by the Medical Research Council of Canada (until 1999), Canadian Institutes of Health Research (CIHR) (1999-present), National Institutes of Health, Canadian Cancer Society, and Cancer Research Society. He has received salary awards from the Fonds de Recherche Quebec Santé and CIHR. He holds a James McGill Professorship and the Minda de Gunzburg Endowed Chair at McGill University. He serves as Editor-in-Chief for Preventive Medicine and Preventive Medicine Reports and serves on the editorial boards of Cancer Epidemiology, Biomarkers & Prevention, International Journal of Cancer, Papillomavirus Research, and Salud Publica de Mexico. He has served as occasional consultant to companies involved with HPV vaccination (Merck and GSK) and HPV diagnostics (Roche, Abbott, Qiagen, and BD).
-
Wendy S Garrett
Harvard T.H. Chan School of Public Health, United States
Wendy Garrett is a Professor of Immunology and Infectious Diseases at the Harvard T. H. Chan School of Public Health, co-Director of the Harvard Chan Center for the Microbiome in Public Health, and an Associate Member of the Broad Institute. Her work explores host-microbiota interactions underlying mucosal immune homeostasis, gastrointestinal inflammatory disorders, and cancer. She graduated from the Yale College; received her MD PhD from Yale University and completed post-graduate training at Harvard.
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Medicine
- Research focus
- host-microbiota interactions
- microbiome
- mucosal immunology
- Competing interests statement
- Wendy Garrett serves on advisory boards of Evelo Biosciences, Kintai Therapeutics, and Leap Therapeutics. She is a member of the Cell Reports and Journal of Clinical Microbiology editorial boards.
-
Diane M Harper
University of Michigan, United States
Diane M Harper, MD, MPH, MS, completed her undergraduate and graduate degrees at the Massachusetts Institute of Technology in Cambridge, Massachusetts, in the fields of Chemical Engineering and Polymerics. She received her medical and public health degrees from the University of Kansas in Kansas City, where she also did residencies in Gynecology/Obstetrics and Family Medicine. Dr Harper has spent the majority of her professional career at Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, as clinician, teacher and researcher in the Departments of Obstetrics and Gynecology, Community and Family Medicine and Women’s and Gender Studies, including improving life for LGBTQ.
She has received the Society of Teachers of Family Medicine (STFM) Excellence in Education Award and the Curtis Hames Research Award honoring her for changing medical care for women through evidence based research. She served as the Chair of Family and Geriatric Medicine at the University of Louisville during which time she also served on the United States Preventive Services Task Force.
She currently is a tenured Professor at the University of Michigan, serving as the Director for Research Management within the Michigan Institute of Clinical and Health Research, one of 50 Clinical and Translational Science Award Research Hubs across the United States. To date she has over 250 peer reviewed publications with over 27,000 citations, and over 40,000 downloads of her seminal review of HPV vaccines.
While at Dartmouth she developed and directed the Gynecologic Cancer Prevention Research Group based at the Norris Cotton Cancer Center in which research on all aspects of HPV associated diseases, specifically cervical cancer prevention was conducted. She is an internationally recognized expert on Human Papillomavirus, the cause of cervical cancer, and its prophylactic and therapeutic vaccines. She has published the seminal clinical research on HPV vaccines and lectured internationally in over 100 countries. She has served on NCI research committees, European research study sections, addressed the Council on Foreign Affairs, and served as a technical advisor to the World Health Organization. Dr Harper has been honored as one of the top clinicians in her field in the US, and Family Physician of the Year in New Hampshire in 2006.
- Expertise
- Medicine
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Immunology and Inflammation
- Research focus
- HPV associated diseases
- primary care
- women's health
- cancer precursor detection
- health behaviours
- epidemiology
- cancer screening
- Experimental organism
- human
- Competing interests statement
- Diane Harper has received funding from NCI, NCATS, NHLBI, CDC, multiple national philanthropic organizations, including the American Cancer Society, The Robert Wood Johnson Foundation, and the Susan G Komen Foundation, in addition to state and local funding agencies and collaborations with industry. She serves in editorship capacities on boards including the Annals of Family Medicine, Preventive Medicine Reports, PLoS ONE, and Gynecologic Oncology. She is a peer reviewer for The Lancet, The New England Journal of Medicine, JAMA, among other journals.
-
Christopher L-H Huang
University of Cambridge, United Kingdom
Prof. Christopher Huang is Professor of Cell Physiology in the University of Cambridge. He read Physiology and Clinical Medicine at the Queen’s College, Oxford on a Florence Heale Scholarship award, and his PhD, at the Physiological Laboratory, Cambridge, on a Medical Research Council award. He was then successively, Assistant Lecturer, Lecturer, Reader in the University of Cambridge. His electrophysiological contributions fall in the areas of skeletal muscle excitation-contraction coupling, cellular ionic homeostasis, central nervous system imaging, and cardiac arrhythmogenic mechanisms in genetic Na+, K+ and ryanodine receptor channel, and metabolic models, in addition to authoring/editing 7 books/monographs, and 5 journal theme issues. He was awarded the Brian Johnson, Rolleston (Oxford) and Gedge Prizes (Cambridge), and has been editor for Journal of Physiology, Monographs of the Physiological Society, Biological Reviews, Europace, eLife and Biographical Memoirs of Fellows of the Royal Society and Faculty Opinions Integrative Physiology Section Leader. He was Cambridge Philosophical Society President, served on the British Heart Foundation Advisory Council and Fellowships Committee, and is Sino British Fellowship Trustee (UK).
- Expertise
- Medicine
- Research focus
- cellular muscle electrophysiology
- Ca2+ imaging
- Na+ channel function and pharmacology
- cardiac arrhythmias
- Experimental organism
- mouse
- Competing interests statement
- Current funding: British Heart Foundation (UK); BioMarin Ltd. (UK)Editorial Roles: Europace, ELife, Biographical Memoirs of Fellows of the Royal Society; International Journal of Drug Discovery and PharmacologyOthers: Sino-British Fellowship Trust (UK); Faculty Opinions Integrative Physiology Section Leader.Visiting Professorships: Southwest University, Luzhuo, China; University of Surrey, UK.
-
Caigang Liu
Shengjing Hospital of China Medical University, China
Caigang Liu received his PhD from the China Medical University, and trained clinically at first hospital of China Medical University. Then joined and served as a director of Breast Center Shengjing Hospital of China Medical University in 2016. His current research interests focus on clinical and translational research of oncology. In recent years, he has led a clinical research term to explore the improvement in breast reconstruction surgery and highly safe and effective anti-cancer strategies, along with identification of therapeutic targets and development of small molecular drugs against cancer metastasis. He has led several projects funded by the National Natural Science Foundation, including the discovery of FSIP1 as a new target for anti-HER2 treatment, and is developing a new strategy to reverse anti-HER2 resistance in breast cancer. He is a member of the National Micro-noninvasive Committee of Chinese Medical Association, a vice chairman of the first breast disease branch of China Sexology Association, and a member of the Standing Committee in breast cancer marker collaboration group of Chinese Anti-cancer Association.
- Expertise
- Medicine
- Cancer Biology
- Research focus
- surgical oncology
- oncological clinical trials
- breast cancer translational medicine
- cancer metastasis and drug resistance
- small molecular drug development
- Experimental organism
- human
- mouse
- Competing interests statement
- Caigang Liu is currently funded by the National Natural Science Foundation of China and “Top young talent” project of Liaoning province, China. He now holds a number of patents for anti-tumor small molecular drugs and Traditional Chinese Medicine.
-
Pramod Mistry
Yale University School of Medicine, United States
Pramod Mistry is Professor at Yale University School of Medicine, Medicine, Pediatrics and Cellular & Molecular Physiology and Yale Medicine’s Director of Lysosomal/Gaucher Disease Center. He was born in Kenya and moved to the UK after high school, where he became a junior lab technician to the late Professor Jack Pepys at London’s Brompton Hospital. He went on to complete BSc/PhD/MBBS at the University of London and completed training in Internal Medicine, Gastroenterology and Metabolic Medicine at London’s UCL/Royal Free Hospital School of Medicine and at Addenbrooke’s Hospital, Cambridge. His translational research has been focused on Gaucher disease genotype/phenotype correlations, annotation of distinct phenotypes of GD (i.e., those associated with Parkinson disease, cancers and pulmonary hypertension), discovery of genetic modifiers through WES and scRNAseq, recombinant enzyme replacement therapies, small molecule substrate reduction therapy and biomarker discovery. His lab was among the first to develop and authentic mouse model of non-neuronopathic Gaucher disease that led to the delineation of system-wide involvement triggered by GBA deletion, including immune dysregulation and identification of biomarkers. His lab maintains a large repertoire of mouse model of Gaucher disease type 1 as well as neuronopathic types of Gaucher disease and humanized models. Research in his lab is now informing common diseases, such as cancers, including myeloma, and Parkinson disease.
He has long-standing interest in mentorship of Junior Faculty, post-doctoral trainees and students. He is Core Mentor in Yale’s T32 Award in Investigative Hepatology. He serves on the Executive Committee of Yale’s Liver Center.
His research has been funded by the NIH and Sanofi.
- Expertise
- Medicine
- Research focus
- lysosomal diseases
- Gaucher disease
- metabolic liver diseases
- Competing interests statement
- I receive a research grant from Sanofi. I do not have any other senior editorial roles.
-
Tony Ng
King's College London, United Kingdom
Tony Ng (FMEDSCI, MB ChB, MRCP, FRCPath, PhD) brings a rich spectrum of knowledge and capabilities with clinical experience in treating AIDS patients (with opportunistic infections and cancers) and fundamental immunology skills. He is also a pioneer of molecular imaging in cancer. He was the first person to use antibody based fluorescence lifetime imaging (FLIM) approaches in tumour cells and tissues to monitor protein states and function. He has published on how to visualize protein biochemistry in preclinical models; as well as in patient-derived cancer tissues for establishing in vitro/ companion diagnostics. He has adopted a multidisciplinary approach to understand cancer recurrence and also to stratify molecularly targeted agents in combination with immunotherapy. His research bridges the gap between physics, biology and medicine, particularly in the field of translational cancer research.
For clinical translation, he has the proven ability to coordinate and work cooperatively with colleagues and leaders in a wide variety of disciplines (imaging, cell biology, oncology, bioinformatics, surgery, pathology, genomics, as well as physical science disciplines such as mathematics, physics, chemistry and engineering). He has directed the KCL and UCL Comprehensive Cancer Imaging Centre (CCIC, one of four centres funded by CRUK & EPSRC in the UK) since its inception in 2008. The vision for the CCIC is to develop novel imaging (PET and MRI) technologies and use them in combination with clinicopathological assessment, genomics and in-house nanoscopic imaging to measure protein interactions in the context of interventional trials. In such trial context, the tissue imaging (FLIM histology) approach he has developed and refined over the years is beginning to reveal ErbB/ HER receptor rewiring as a mechanism of resistance in human tumours under selection pressure such as cetuximab.
Tony Ng is the current Director of the Comprehensive Cancer Centre, part of the KCL School of Cancer & Pharmaceutical Sciences, and the National Institute for Health and Care Research (NIHR) Guy’s & St Thomas’ Biomedical Research Centre (BRC) Cancer Theme. In 2022, he joined GSK on a part-time basis, to help establish the GSK-KCL Translational Oncology Research Hub which was which was announced in September 2021. The aim is to apply his clinical medicine training as well as immunology, biochemistry and imaging expertise to accelerate the development of the anti-cancer drugs. HIs experience of collaborating with mathematicians/theoretical physicists creates an opportunity to bridge the biology & AI/ML interface, an essential component of delivering the innovative Digital biological twin vision.
Training/expertise: Medicine, Immunology, Cancer cell biology, Biochemistry and Optical Imaging/Biophysics as well as preclinical Radionuclide imaging.
- Expertise
- Medicine
- Cancer Biology
- Immunology and Inflammation
- Research focus
- imaging
- biomarkers
- trial
- immune
- cancer
- reverse translation
- exosome
- organoid
- tumour microenvironment
- Competing interests statement
- At KCL, Tony Ng receives funding from Cancer Research UK, Medical Research Council, Wellcome Leap Inc., European Commission and GSK. He is employed on a part time basis as the Vice President of the Digital biological twin Unit at GSK.
-
Jonathan Roiser
University College London, United Kingdom
Jonathan Roiser is Professor of Neuroscience and Mental Health and Deputy Director at the UCL Institute of Cognitive Neuroscience. His research interests lie in understanding the brain and psychological processes driving mental health problems, especially disrupted motivation in depression. He has published over 150 peer-reviewed papers and his recent research has been funded by Wellcome, the MRC, the Leverhulme Trust and the Rosetrees Trust. He founded and directs two PhD schemes: the UCL-NIMH Joint Doctoral Training Program in Neuroscience and the UCL Wellcome 4-year PhD Programme in Mental Health Science.
- Expertise
- Neuroscience
- Medicine
- Research focus
- mental health
- neuroimaging
- behavior
- psychopharmacology
- computational modelling
- Experimental organism
- human
- Competing interests statement
- I hold active grants from Rosetrees, Wellcome and the Leverhulme Trust. I supervise an ongoing PhD studentship co-funded by MRC and Cambridge Cognition Ltd. I have performed paid consultancy work for GE Ltd within the last 3 years. I sit on the Editorial Board of Current Opinion in Behavioral Sciences.
-
Dolores Shoback
University of California, San Francisco, United States
Dr Dolores Shoback cares for patients with a variety of disorders related to the endocrine system, focusing particularly on metabolic bone disease, parathyroid disorders and osteoporosis. She also directs UCSF's physician training program in diabetes, endocrinology and metabolism.
Shoback's research interests include metabolic bone disease, the calcium-sensing receptor and parathyroid hormone.
Shoback completed her undergraduate studies at the University of Pennsylvania. She earned her MD from the Johns Hopkins School of Medicine and completed a residency in internal medicine at the Johns Hopkins Hospital. She completed a fellowship in endocrinology at Brigham and Women's Hospital.
- Expertise
- Medicine
- Research focus
- endocrinology
- hormones
- bone metabolism
- calcium
- mineral
- parathyroid
- vitamin D
- Experimental organism
- human
- mouse
- Competing interests statement
- Dr Shoback is currently funded by the NIH.
-
Lois Smith
Harvard Medical School, Children's Hospital Boston, United States
Lois EH Smith MD, PhD is an ophthalmologist and clinician/scientist at Boston Children’s Hospital and Professor of Ophthalmology at Harvard Medical School. Her basic research work is in retinal neovascularization, both basic mechanism and treatment including diabetic retinopathy, retinopathy of prematurity, age-related macular degeneration and retinitis pigmentosa.
She has a long standing interest in eye diseases particularly retinopathy of prematurity, diabetic retinopathy, and AMD and in the mechanisms behind these diseases, particularly the underlying causes of neovascularization and the interactions between neurons and vessels. Many pathways that they have found have been translated into clinical trials, including replacement of IGF-1 in preterm infants and treatment of AMD with anti-VEGF antibodies in which they were the first to show the benefit of blocking VEGF in a mouse model of retinopathy. More recently Dr Smith's work has been interested in metabolic function in photoreceptors, particularly with respect to lipids. Photoreceptor metabolic dysfunction causes central vision loss in retinal degenerative diseases (including ROP) but is also implicated in age-related macular degeneration and diabetic retinopathy.
Dr Smith is the recipient of the Friedenwald award, the Alcon Research Institute award, the Silverman award, and the Bressler Prize.
- Expertise
- Developmental Biology
- Medicine
- Neuroscience
- Research focus
- age-related macular degeneration
- diabetic eye disease
- retinopathy
- ocular disease
- developmental neuroscience
- Competing interests statement
- Dr Smith has received funding from the National Eye Institute, Massachusetts Lions Eye Research Fund, the European Union, the Lowy Medical Research Institute, Foundation Fighting Blindness, Research to Prevent Blindness Senior Investigator Award, and the Alcon Award.Current editor roles include: Editor for Ophthalmology (Science), Editor for Journal of Clinical Ophthalmology, and Editor IOVS (Investigative Ophthalmology and Visual Science).
-
Richard M White
Ludwig Institute for Cancer Research, University of Oxford, United Kingdom
Richard White, M.D., Ph.D, is a physician-scientist at the Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College. He is interested in basic mechanisms underlying metastasis, using the zebrafish as a model system. His work has established numerous techniques for cancer modeling and high-resolution imaging in the fish. Using these tools, the lab is focused on the cross-talk between tumor cells and the microenvironment, and how this interplay influences metastatic success. His work has revealed novel interactions between melanoma cells and adipocytes in the microenvironment, and how neural crest programs play roles in melanoma progression. He has been awarded the NIH Director’s New Innovator Award, the Pershing Square Foundation Award, and the Mark Foundation ASPIRE award.
- Expertise
- Cancer Biology
- Cell Biology
- Developmental Biology
- Medicine
- Research focus
- development
- neural crest
- zebrafish
- cancer
- melanoma
- metastasis
- microenvironment
- Experimental organism
- zebrafish
- Competing interests statement
- Richard White receives funding from the National Institutes of Health, the Pershing Square Sohn Foundation, the Mark Foundation, the Melanoma Research Alliance, the American Cancer Society and the Harry J. Lloyd Foundation. He receives consulting fees from N-of-One, Inc.
-
Ma-Li Wong
State University of New York Upstate Medical University, United States
Ma-Li Wong, MD, PhD, FRANZCP, is Professor in the Department of Psychiatry and Behavioral Sciences, and Neurosciences and Physiology at SUNY Upstate Medical University. She was born in Hong Kong and grew up in Brazil, where she graduated from the University of São Paulo School of Medicine (FMUSP). She had clinical and research training in psychiatry at Albert Einstein College of Medicine, NIH, and Yale University. Ma-Li Wong is a bench, clinical and translational researcher in the biology of depression and co-morbid conditions, chronic stress, and antidepressant drugs. She has conducted research for over 30 years at Yale (Chief Resident and Instructor), National Institutes of Health (Unit Chief), University of California, Los Angeles (Professor), University of Miami (Professor and Vice-Chair), and in Australia (Australian National University, South Australian Health and Medical Research Institute, and Flinders University). She was the recipient of the following awards: Milton Rosenbaum Award for Psychiatric Research (1989); Lilly Psychiatric Research Fellowship by the American Psychiatric Association (1990); SmithKline Beecham Award by the Society of Biological Psychiatry (1990); APA/Dista Research Award (1993); NIH Fare Award (1996 and 1997); Henry L. Moses Award by the Montefiore Medical Center (1998). She co-edited two books: Pharmacogenomics: The Search for Individualized Therapeutics (2002) and Biology of Depression: From Novel Insights to Therapeutic Strategies (2005).
- Expertise
- Medicine
- Neuroscience
- Research focus
- major depression
- chronic stress
- neuroinflammation
- neuroendocrinology
- pharmacogenomics
- genetics
- obesity
- leptin
- Experimental organism
- human
- mouse
- primary cells
- immortalized cells
- Competing interests statement
- Ma-Li Wong is an Associate Editor for Molecular Psychiatry. She has been funded by organizations such as the NIH in the US and the National Health and Medical Research Council in Australia.
-
Wei Yan
University of California, Los Angeles, United States
Wei Yan obtained his MD from China Medical University and PhD from University of Turku, Finland. After finishing his post-doc training at Baylor College of Medicine, Houston, TX, he started his own lab at the University of Nevada School of Medicine, where he rose through the ranks and eventually named University Foundation Professor, the highest honor the University bestows upon its faculty. In 2020, he joined The Lundquist Institute at Harbor-UCLA to direct the newly established National Center for Male Reproductive Epigenomics, one of the seven National Centers for Translational Research in Reproduction and Infertility (NCTRI) supported by the NICDH. The Yan lab works on genetic and epigenetic control of fertility and the epigenetic contribution of gametes to fertilization, early embryonic development, and adulthood health. He has so far published over 160 peer-reviewed research articles and book chapters with over 12,00 citations.
His lab first put forward a novel idea for the development of non-hormonal male contraceptives: “Do not kill, but disable sperm”, which led to the discovery of TRIPTONIDE, a natural compound, as a reversible non-hormonal contraceptive agent in mice and monkeys, and established it as a drug candidate for “The Pill” for men. His lab also discovered the function of motile cilia in the reproductive tracts. In the male, motile ciliary beating function as an agitator to maintain the constant suspension of immotile testicular sperm during their transit through the efferent ductules in men. In the female, motile cilia in the oviduct/Fallopian tube are essential for oocyte pickup and fertility, but dispensable for embryo and sperm transport, which are mostly achieved through smooth muscle contraction. This discovery solved the long-standing controversy about the role of cilia beating vs. muscle contraction in gamete/embryo transport. His lab elucidated several novel mechanisms underlying the unique regulation of gene expression during the haploid phase of spermatogenesis, including global shortening of transcripts, delayed translation/uncoupling of transcription and translation, and dynamic changes in poly(A) length and non-A contents. His lab first discovered mitochondrial genome-encoded small RNAs (mitosRNAs), endo-siRNAs in the male germline and MSCI-escaping X-linked miRNAs. His lab was also among those that suggested critical functions of sperm-borne RNAs in supporting early embryonic development and epigenetic inheritance.
Wei Yan’s contributions to science have been recognized by several academic awards, including the 2009 Society for the Study of Reproduction (SSR) Young Investigator Award, the 2012 American Society of Andrology (ASA) Young Andrologist Award, the 2013 Nevada Healthcare Hero Award for Research and Technology, the 2017 University of Nevada, Reno Outstanding Researcher Award, the 2018 SSR Research Award and the 2020 Nevada System of Higher Education Research Award. Dr Yan was elected Fellow of the American Association for the Advancement of Science (AAAS) in 2017 and SSR Distinguished Fellow in 2023.
- Expertise
- Developmental Biology
- Genetics and Genomics
- Medicine
- Research focus
- reproduction
- epigenetic inheritance
- regulation of spermatogenesis
- female infertility
- sperm biology
- reproductive tract
- ovarian biology
- female fertility
- contraceptive development
- endocrine control of reproduction and fertility
- germline epigenetic reprogramming
- sperm-borne large and small RNA
- Competing interests statement
- The Yan lab receives funding from the NIH, Male Contraceptive Initiative, and John Templeton Foundation. Wei Yan serves on the Advisory Board of Contraceptive Accelerator Network, LLC. Wei Yan served as co-Editor-in-Chief of Biology of Reproduction (2017-2021). He serves as Associate Editor for Environmental Epigenetics and Reviewing Editor for FASEB journal.
-
Tony Yuen
Icahn School of Medicine at Mount Sinai, United States
Tony Yuen, PhD, is Associate Professor and Research Director of the Center for Translational Medicine and Pharmacology at Icahn School of Medicine at Mount Sinai. As an early adopter of systems biology techniques, Dr Yuen has extensive experience in gene expression profiling. His group showed that, while both hallucinogenic and non-hallucinogenic chemicals activate the serotonin 2A receptor (5HT2AR), their transcriptome fingerprint is distinct. Their discovery that 5HT2AR forms a functional complex with the metabotropic glutamate receptor mGluR2 to trigger hallucinogenic responses suggests that the 5HT2AR/mGluR2 complex is a promising new target for the treatment of psychosis. Together with Dr Maria New, Dr Yuen established genotype–genotype correlations in 1507 patients with congenital adrenal hyperplasia (CAH) and have used an in silico approach of molecular modeling to define precisely the structural defect in the enzyme from a given mutation. Additionally, in collaboration with Lasker Awardee Professor Dennis Lo, by targeted deep sequencing of fetal DNA in maternal plasma, they have established the feasibility of prenatal diagnosis of CAH as early as 6 weeks of pregnancy with 100% reliability. Furthermore, Dr Yuen demonstrated that bisphosphonates, the most widely used class of drugs for osteoporosis and skeletal metastases, bind directly to the kinase domain of the human EGF family of receptors. He found that these drugs inhibit cell signaling and reduce cell viability in vitro. Xenotransplant studies have documented potent effects of bisphosphonates on the growth of EGFR–positive human tumor cells. These studies lay the basis for repurposing bisphosphonates towards the treatment and prevention of EGFR–driven cancers, in addition to the known benefit of these agents in ameliorating cancer metastases. Dr. Yuen is also deeply involved in skeletal and metabolic phenotyping of mice to understand the effects of FSH inhibition on bone remodeling, bone mass, fat mass and energy homeostasis. More recently, based on the collaborative findings with Dr Keqiang Ye that FSH inhibition prevents neuropathology and cognitive decline in Alzheimer’s disease models, Dr Yuen have developed a new and evolving interest in neurodegeneration. Thus, his current research focus is on understanding the biology of FSH action on the brain, as well as on dissecting the relationship between serum FSH levels and cognition as a function of aging.
- Expertise
- Medicine
- Research focus
- Mendelian genetics
- rare diseases
- cancer therapeutics
- pituitary hormones
- neurodegeneration
- osteoporosis
- obesity
- Competing interests statement
- Current NIH funding: R01AG071870 (2021–2026), U01AG073148 (2021–2026), R01AG074092 (2021–2026), R01DK107670 (2022–2026). Other editorial roles: Associate Editor, Frontiers in Pediatrics; Associate Editor, Frontiers in Endocrinology; Associate Editor, Genetic Steroid Disorders; Associate Editor, Encyclopedia of Bone Biology.
Reviewing editors
-
Yousef Abu-Amer
Washington University School of Medicine, United States
- Expertise
- Cell Biology
- Immunology and Inflammation
- Medicine
- Research focus
- osteolysis
- osteoclast
- osteoarthritis
- osteoimmunology
- inflammatory arthritis
- RANKL
-
Iannis E Adamopoulos
Harvard Medical School, United States
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- osteoclasts
- arthritis
- psoriatic arthritis
- interleukin 23
- interleukin 17
- RANKL
-
Anurag Agrawal
CSIR Institute of Genomics and Integrative Biology, India
- Expertise
- Medicine
- Research focus
- asthma
- respiratory diseases
- Experimental organism
- human
- mouse
-
Clara Akpan
Michael Okpara University of Agriculture, Nigeria
- Expertise
- Medicine
- Research focus
- veterinary medicine
- ruminants
- animal health
- treatment of animals
-
Joon-Yong An
Korea University, South Korea
- Expertise
- Medicine
- Computational and Systems Biology
- Genetics and Genomics
- Neuroscience
- Research focus
- whole genome sequencing
- noncoding mutation
- neurodevelopment
- autism spectrum disorders
- multi-omics
-
Rozalyn M Anderson
University of Wisconsin-Madison, United States
- Expertise
- Cell Biology
- Medicine
- Research focus
- aging
- metabolism
- caloric restriction
-
Cynthia L Andoniadou
King's College London, United Kingdom
- Expertise
- Developmental Biology
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- stem cells
- endocrine
- pituitary gland
- adrenal gland
- paracrine signalling
- tumours
- Experimental organism
- human
- mouse
-
Wadih Arap
Rutgers Cancer Institute of New Jersey at University Hospital, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- clinical oncology
- genitourinary (GU) cancers
- prostate cancer
-
Hossein Ardehali
Northwestern University, United States
- Expertise
- Medicine
- Biochemistry and Chemical Biology
- Research focus
- mitochondria
- iron
- glucose metabolism
- mRNA-binding proteins
- hexokinases
- metabolism
- cardiac biology
-
Robert Baiocchi
The Ohio State University, United States
- Expertise
- Medicine
- Cancer Biology
- Immunology and Inflammation
- Research focus
- Epstein Barr Virus
- lymphoma
- cancer therapeutics
- cancer vaccines
- cancer immunology
- cancer immunotherapy
- cancer epigenetics
-
Bubu Banini
Yale School of Medicine, United States
- Expertise
- Medicine
- Research focus
- NASH
- alcohol associated liver disease
-
Audrey M Bernstein
State University of New York Upstate Medical University, United States
- Expertise
- Cell Biology
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- cornea
- scarring
- fibrosis
- glaucoma
- integrins
- myofibroblast
-
José Biurrun Manresa
National Scientific and Technical Research Council (CONICET), National University of Entre Ríos (UNER), Argentina
- Expertise
- Medicine
- Neuroscience
- Research focus
- pain
- nociceptive system
- EEG
- EMG
- biomedical signal processing
- biostatistics
-
Jonathan S Bogan
Yale School of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- insulin
- protein trafficking
- metabolism
- type 2 diabetes
-
Marc J Bonten
University Medical Center Utrecht, Netherlands
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology
- antibiotic resistance
- healthcare-associated infections
- prevention
- clinical trials
-
Philip Boonstra
University of Michigan, United States
- Expertise
- Medicine
- Epidemiology and Global Health
- Cancer Biology
- Genetics and Genomics
- Research focus
- biostatistics
- clinical trials
- cancer biostatistics
- epidemiology
- ECMO
- statistical programming
-
Annelien Bredenoord
University Medical Centre Utrecht, Netherlands
- Expertise
- Medicine
- Research focus
- bioethics
- medical ethics
- ethics
-
Christoph Buettner
Rutgers Robert Wood Johnson Medical School, United States
- Expertise
- Medicine
- Research focus
- metabolism
- diabetes
-
Hayriye Cagnan
University of Oxford, United Kingdom
- Expertise
- Neuroscience
- Medicine
- Computational and Systems Biology
- Research focus
- brain stimulation
- brain computer interfacing
- computational neuroscience
- motor control
- Parkinson's disease
- tremor
- close-loop neuromodulation
-
Ernesto Canalis
UConn Health, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- osteoblasts
- osteoclasts
- mouse genetics
- rare diseases
- notch
-
Jay J Cao
United States Department of Agriculture, United States
- Expertise
- Medicine
- Research focus
- bone metabolism
- obesity
-
Marlon Cerf
South African Medical Research Council, South Africa
- Expertise
- Cell Biology
- Medicine
- Research focus
- diabetes
- cardiovascular disease
- SDGs
- fetal programming
- obesity
-
Snigdha Chaturvedi
University of North Carolina, Chapel Hill, United States
- Expertise
- Medicine
- Research focus
- nature language processing
- narrative understanding
-
Hina W Chaudhry
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- cardiac regeneration
- cardiomyocytes
- developmental genetics
- stem cell biology
- regenerative biology
-
Di Chen
Shenzhen Institute of Advanced Technology, China
- Expertise
- Medicine
- Research focus
- bone disease
-
Iacopo Chiodini
Ospedale Niguarda Ca' Granda, Italy
- Expertise
- Medicine
- Research focus
- adrenal gland
- bone metabolism
- osteoporosis
- calcium metabolism
- bone fragility
-
Jungmin Choi
Korea University College of Medicine, South Korea
- Expertise
- Cancer Biology
- Computational and Systems Biology
- Genetics and Genomics
- Medicine
- Research focus
- rare disorders
- single cell genomics
- computational biology
- human genomics
-
Graziana Colaianni
University of Bari, Italy
- Expertise
- Medicine
- Cell Biology
- Stem Cells and Regenerative Medicine
- Research focus
- bone
- osteoporosis
- muscle
- sarcopenia
- cartilage
- muscle atrophy
- Experimental organism
- mouse
- human
-
Yali Cong
Peking University Health Science Center, China
- Expertise
- Medicine
- Research focus
- medical ethics
- bioethics
-
Seth J Corey
Cleveland Clinic, United States
- Expertise
- Cancer Biology
- Medicine
- Research focus
- myeloid malignancies
- inherited or acquired bone marrow failure
- neutrophils
- platelets zebrafish
- cancer evolution
- proteostasis
-
Jennifer Cullen
Case Western Reserve University, United States
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer population sciences
-
Ilse S Daehn
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- mitochondria
- glomerular disease
- podocyte
- endothelial cells
- reactive oxygen species
-
Alok Dhawan
Centre of Biomedical Research, India
- Expertise
- Medicine
- Ecology
- Research focus
- molecular epidemiology
- DNA damage and repair
- genetic toxicology
- nanomaterial toxicology
- environmental health
-
Rajan Dighe
Indian Institute of Science Bangalore, India
- Expertise
- Medicine
- Research focus
- reproductive endocrinology
-
Ana Domingos
University of Oxford, United Kingdom
- Expertise
- Medicine
- Neuroscience
- Research focus
- metabolism
- obesity
- neuroimmunity
- autonomic nervous system
- eating behaviour
- inflammation
-
Hannelore Ehrenreich
Max Planck Institute of Experimental Medicine, Germany
- Expertise
- Genetics and Genomics
- Immunology and Inflammation
- Medicine
- Neuroscience
- Research focus
- translational neuroscience
- erythropoietin
- hypoxia
- neuropsychiatric phenotypes
- deep phenotyping
- autoantibodies
- Experimental organism
- human
-
Noriaki Emoto
Kobe Pharmaceutical University, Japan
- Expertise
- Medicine
- Research focus
- cardiology
- pulmonary hypertension
- endothelin
- pharmacology
- vascular biology
-
Carlos Escande
Institut Pasteur de Montevideo, Uruguay
- Expertise
- Medicine
- Structural Biology and Molecular Biophysics
- Research focus
- atherosclerosis
- inflammatory diseases
- metabolism
- obesity
- type 2 diabetes
-
John Ewer
Universidad de Valparaiso, Chile
- Expertise
- Developmental Biology
- Neuroscience
- Genetics and Genomics
- Medicine
- Research focus
- animal behaviour
- neuropeptides
- circadian clocks
- insect endocrinology
- Experimental organism
- D. melanogaster
-
Alberto Falchetti
Istituto Auxologico Italiano , IRCCS, Italy
- Expertise
- Medicine
- Research focus
- metabolic bone disease
- Paget's disease of bone
- familial primary hyperparathyroidism
- multiple endocrine neoplasia type 1
-
Edward A Fisher
New York University Grossman School of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- preventive cardiology
- cardiology
- lipoprotein metabolism
- atherosclerosis
- Experimental organism
- mouse
-
Jonathan Flint
University of California, Los Angeles, United States
- Expertise
- Genetics and Genomics
- Medicine
- Research focus
- genetics
- genomics
- psychiatric disorders
-
Zhongjie Fu
Boston Children's Hospital/Harvard Medical School, United States
- Expertise
- Medicine
- Research focus
- retinal vasculature
- retinopathy
- adiponectin
-
Dipyaman Ganguly
Indian Institute of Chemical Biology, India
- Expertise
- Immunology and Inflammation
- Medicine
- Cell Biology
- Microbiology and Infectious Disease
- Research focus
- cellular immunology
- inflammation
- dendritic cells
- cell migration
- endocytosis
- autoimmune diseases
- infectious diseases
-
Mari Gantner
The Lowy Medical Research Institute, United States
- Expertise
- Biochemistry and Chemical Biology
- Cell Biology
- Medicine
- Research focus
- retinal disease
- retinal metabolism
- patient metabolomics
- amino acid metabolism
- sphingolipid biology
- Retinal pigment epithelium (RPE) biology
-
Bo Gao
The Chinese University of Hong Kong, Hong Kong SAR China
- Expertise
- Cell Biology
- Developmental Biology
- Medicine
- Research focus
- planar cell polarity
- scoliosis
- skeletal disease
- wnt signaling
-
Luigi Gennari
University of Siena, Italy
- Expertise
- Medicine
- Research focus
- metabolic bone disease
- Paget's disease of bone
- endocrinology
-
Gregory G Germino
National Institute of Diabetes and Digestive and Kidney Diseases, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- nephrology
- genetic renal disease
- internal medicine
- ciliopathies
- Experimental organism
- mouse
- rat
- human
-
Evangelos J Giamarellos-Bourboulis
Attikon University Hospital, Greece
- Expertise
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Genetics and Genomics
- Medicine
- Research focus
- sepsis
- hidradenitis suppurativa
- pathogenesis of infection
- biomarkers
-
David Ginsburg
University of Michigan, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- hemostasis
- thrombosis
- protein secretion
- human genetics
- fibrinolysis
- Experimental organism
- human
- mouse
- zebrafish
-
Pablo A González
Pontificia Universidad Católica de Chile, Chile
- Expertise
- Medicine
- Microbiology and Infectious Disease
- Research focus
- host-pathogen interactions
- dendritic cells
- T cells
- herpesviruses
- bacteria
- immune evasion
- viruses
- Experimental organism
- mouse
-
Ki Goosens
ki.goosens@mssm.edu, United States
- Expertise
- Neuroscience
- Medicine
- Research focus
- chronic stress
- translational science
- systems neuroscience
- brain-body interactions
-
Yogesh K Gupta
The University of Texas Health Science Center at San Antonio, United States
- Expertise
- Medicine
- Structural Biology and Molecular Biophysics
- Cancer Biology
- Microbiology and Infectious Disease
- Research focus
- drug discovery
- nucleic acid modifications
- cancer epigenetics
- structures of viral proteins
- host-pathogen interactions
-
Aditi U Gurkar
University of Pittsburgh, United States
- Expertise
- Medicine
- Chromosomes and Gene Expression
- Cell Biology
- Research focus
- aging
- cellular senescence
- DNA damage and repair
- metabolism
- cardiac disease and aging
-
Adam Haber
Harvard TH Chan School of Public Health, United States
- Expertise
- Computational and Systems Biology
- Genetics and Genomics
- Medicine
- Research focus
- asthma
- machine learning
-
Shozeb Haider
University College London, United Kingdom
- Expertise
- Medicine
- Structural Biology and Molecular Biophysics
- Computational and Systems Biology
- Microbiology and Infectious Disease
- Research focus
- X-ray crystallography
- molecular dynamics simulations
- allostery
- structure-based drug design
- structural bioinformatics
- computational chemistry
- nucleic acids
- rare diseases
-
Sang Jun Han
Baylor College of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- nuclear receptors
- steroid receptor coactivator
- endometriosis
- female infertility
-
Gaiti Hasan
Tata Institute of Fundamental Research, National Centre for Biological Sciences, India
- Expertise
- Genetics and Genomics
- Neuroscience
- Medicine
- Research focus
- calcium signaling
- motor function
- regulation of gene expression
- IP3R
- STIM
- Orai
- Experimental organism
- D. melanogaster
-
Shannon M Hawkins
Indiana University School of Medicine, United States
- Expertise
- Medicine
- Research focus
- endometriosis
- ovarian cancer
- endometrial cancer
-
Daniel Henrion
University of Angers, France
- Expertise
- Cell Biology
- Medicine
- Research focus
- vascular biology
- endothelium
- blood flow
- vascular remodeling
- hypertension
- blood pressure
- shear stress
- vascular diseases
-
Elizabeth P Henske
Brigham And Women's Hospital, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- tuberous sclerosis complex
- lymphangioleiomyomatosis
- mTOR
- prostate cancer
-
Kenneth Ho
Garvan Institute of Medical Research, Australia
- Expertise
- Medicine
- Research focus
- metabolism
- sarcopenia
-
Patrick J Hu
Vanderbilt University School of Medicine, United States
- Expertise
- Medicine
- Developmental Biology
- Genetics and Genomics
- Research focus
- signal transduction
- genetics
- development
- aging
- cancer
- endoplasmic reticulum homeostasis
- dauer
- Experimental organism
- C. elegans
-
Susie Y Huang
Massachusetts General Hospital, United States
- Expertise
- Medicine
- Neuroscience
- Research focus
- development
- translation
- magnetic resonance imaging
-
Bradley Hyman
Massachusetts General Hospital, United States
- Expertise
- Medicine
- Neuroscience
- Research focus
- tau
- alzheimer
- neuropathology
-
Jameel Iqbal
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- general pathology
- blood banking
- transfusion medicine
- transplantation immunology
- clinical pathology
-
Edward D Janus
University of Melbourne, Australia
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cardiovascular disease
- diabetes
- prevention
- chronic diseases
- clinical guidelines
-
Jae-Wook Jeong
University of Missouri – Columbia, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- estrogen
- endometriosis
- uterus
- endometrium
- endometrial cancer
- implantation
- decidualization
- progesterone
-
Loydie A Jerome-Majewska
McGill University, Canada
- Expertise
- Developmental Biology
- Cell Biology
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- splicing
- protein transport
- neural crest cells
- Experimental organism
- mouse
-
Prabhat Jha
Saint Michael's Hospital, Canada
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- epidemiology
- global health
- infectious disease and population dynamics
- randomized controlled trials
-
Yaoting Ji
Wuhan University, China
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Cell Biology
- Research focus
- osteoporosis
- obesity
- stem cell differentiation
- aging
- beiging
- skeletal mineralization
- bone resorption
-
Jean Jiang
The University of Texas Health Science Center at San Antonio, United States
- Expertise
- Medicine
- Cell Biology
- Cancer Biology
- Research focus
- gap junctions
- hemichannels
- connexins
- bone biology
- osteocyte
- bone mechanobiology
- cancer bone metastasis
- lens biology
-
Mohammad M Karimi
Kings College London, United Kingdom
- Expertise
- Medicine
- Computational and Systems Biology
- Research focus
- bioinformatics
- genomics
- epigenomics
- transposable elements
- single-cell sequencing
- visual analytics
- epigenetic therapy
-
Omowumi Kayode
Mountain Top University, Nigeria
- Expertise
- Biochemistry and Chemical Biology
- Cancer Biology
- Cell Biology
- Immunology and Inflammation
- Medicine
- Research focus
- biochemistry
- nutrition
- cancer
- male sexual function
- reproductive tissues
-
Brian S Kim
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Immunology and Inflammation
- Neuroscience
- Research focus
- basophil
- cytokine
- innate lymphoid cell
- itch
- mast cells
- neuroimmunology
- sensory neuron
- somatosensation
-
Se-Min Kim
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- metabolic bone disease
- diabetic bone disease
- thyroid bone disease
- phosphodiesterase (PDE)5
- PDE11
-
Smita Krishnaswamy
Yale School of Medicine, United States
- Expertise
- Medicine
- Research focus
- bioinformatics
- computational genomics
- immunology
- immunotherapy
- cancer
- neuroscience
- developmental biology
-
Dudley W Lamming
University of Wisconsin-Madison, United States
- Expertise
- Medicine
- Biochemistry and Chemical Biology
- Research focus
- aging
- physiology
- dietary restriction
- amino acids
- diabetes
- obesity
- metabolism
- protein
- Experimental organism
- mouse
-
Emmanuel Lamptey
KAAF University College, Ghana
- Expertise
- Cancer Biology
- Epidemiology and Global Health
- Immunology and Inflammation
- Medicine
- Research focus
- health literacy
- health communication
- health promotion
- health education
- patient education
- chronic diseases
- geriatric assessment
- neoplasm
-
Dan Larhammar
Uppsala University, Sweden
- Expertise
- Medicine
- Evolutionary Biology
- Neuroscience
- Cell Biology
- Chromosomes and Gene Expression
- Genetics and Genomics
- Research focus
- evolution
- gene/genome duplications
- cellular and molecular neuroscience
- G protein-coupled receptors (GPCR)
- neuropeptides
- endocrine peptides
- phototransduction
- ligand-gated ion channels
- Experimental organism
- human
- zebrafish
-
Rauf Latif
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Cell Biology
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- metabolic syndrome
- thyroid
- GPCRs
- glycoprotein hormone receptors
- TSH receptor
- thyroid hormones
- receptor oligomerization
- post translational modification of receptors
- Experimental organism
- mouse
-
Sihoon Lee
Gachon University College of Medicine, South Korea
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- endocrinology
- hormones
- parathyroid
- bone metabolism
- rare diseases
- thyroid hormone metabolism
- deiodinase
- insulin resistance
-
Ellis Levin
University of California, Irvine, United States
- Expertise
- Medicine
- Research focus
- signal transduction in cells
- steroid receptors
-
Huihui Li
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Cell Biology
- Microbiology and Infectious Disease
- Research focus
- sickle cell disease
- gut microbiota
- iron
- polycythemia vera
- bacteria-induced organ damage
- Experimental organism
- mouse
-
Paloma B Liton
Duke University School of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- ophthalmology
- glaucoma
- trabecular meshwork
- autophagy
- mechanical stretch
- lysosomes
- senescence
- lysosomal enzymes
- fibrosis
-
Huiping Liu
Northwestern University, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- cancer stem cells
- circulating tumor cells
- exosome
- cancer immunity
- metastasis
- breast cancer
-
Mengfei Liu
Yale University, United States
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- hepatology
- liver disease
- alcohol
-
Nianjun Liu
Indiana University Bloomington, United States
- Expertise
- Medicine
- Research focus
- biostatistics
- applied statistics
- computational methods
- human health and diseases
-
Peng Liu
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- obesity
- aging
- osteoporosis
- Adipose Biology
- Bone Biology (osteoblasts and osteoclasts)
-
Xiaorong Liu
University of Virginia, United States
- Expertise
- Neuroscience
- Medicine
- Research focus
- retina
- retinal ganglion cell
- retinal degeneration
- glaucoma
- in vivo imaging
- optic nerve
- axon bundles
- Experimental organism
- mouse
- tree shrew
-
Daria Lizneva
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- endocrinology
- polycystic ovary syndrome (PCOS)
-
Francesc Lopez-Giraldez
Yale University, United States
- Expertise
- Medicine
- Research focus
- bioinformatics
-
Mychael V Lourenco
Federal University of Rio de Janeiro, Brazil
- Expertise
- Cell Biology
- Medicine
- Neuroscience
- Research focus
- Alzheimer's disease
- synaptic plasticity
- translational control
- hormones
- memory
- neurodegeneration
- biomarkers
-
Helen H Lu
Columbia University, United States
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- bioengineering
- biomechanics
- orthopaedics
- tissue engineering
-
Arduino A Mangoni
Flinders Medical Centre, Australia
- Expertise
- Medicine
- Research focus
- pharmacology
- drug safety
- metabolomics
- biomarkers
- drug discovery
- hypertension
-
Arya Mani
Yale University School of Medicine, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- lipid metabolism
- glucose metabolism
- fatty liver disease
- hyperlipidemia
- cardiovascular genetics
- Experimental organism
- mouse
-
Juan P Martinez-Barbera
University College London, United Kingdom
- Expertise
- Medicine
- Cancer Biology
- Developmental Biology
- Research focus
- brain
- pituitary
- tumour and cancer
- embryos
- cell senescence
- senescence-associate secretory phenotype (SASP)
- senolytic
- Experimental organism
- mouse
-
Gherardo Mazziotti
Humanitas University of Milan, Italy
- Expertise
- Medicine
- Research focus
- endocrinology
- pituitary disease
- growth hormone
- thyroid
- FSH
- thyroid diseases
- secondary osteoporosis
- insulin-like growth factor-1
- ACTH
- cortisol
- prolactin
- TSH
- PTH
-
Simón Méndez-Ferrer
University of Cambridge, United Kingdom
- Expertise
- Stem Cells and Regenerative Medicine
- Developmental Biology
- Cancer Biology
- Medicine
- Research focus
- haematopoietic stem cell niche
- mesenchymal stem cells
- myeloproliferative neoplasms
- acute myeloid leukemia
- neuroimmunology
-
Salem Y Mohamed
Zagazig University, Egypt
- Expertise
- Cancer Biology
- Cell Biology
- Chromosomes and Gene Expression
- Epidemiology and Global Health
- Genetics and Genomics
- Immunology and Inflammation
- Medicine
- Microbiology and Infectious Disease
- Research focus
- advanced endoscopy
- cell biology
- cancer
- inflammation
- genetics
- basic medicine
-
Subburaman Mohan
Loma Linda University, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- bone biology
- endochondral bone formation
- insulin-like growth factors
- osteoporosis
- osteoarthritis
- skeletal development
- Experimental organism
- human
-
Zsolt Molnár
CytoSorbents Europe GmbH, Germany
University of Pécs, Hungary- Expertise
- Medicine
- Research focus
- sepsis
- septic shock
- hemodynamic monitoring
- fluid therapy
- extracorporeal cytokine removal
-
Tomohiro Morio
Tokyo Medical and Dental University, Japan
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- primary immunodeficiency
- pediatrics
- cell therapy
- monogenic disorder
- iPS cells
-
Roberto Motterlini
INSERM U955, University Paris Est, France
- Expertise
- Medicine
- Research focus
- cardiovascular disease
- metabolism
- pharmacology
- inflammation
- oxidative stress
- heme oxygenase
- carbon monoxide
-
Shiny Nair
Yale University, United States
- Expertise
- Medicine
- Immunology and Inflammation
- Cancer Biology
- Research focus
- immunology
- neurodegeneration
- NKT cells
- mycobacterium
- lysosomal storage disorder
-
Nicola Napoli
Campus Bio-Medico University of Rome, Italy
- Expertise
- Medicine
- Research focus
- endocrinology
- metabolism
- osteoporosis
- bone fragility in diabetic reactions
- diabetes
- obesity
- clinical trials
- Experimental organism
- human
-
Anjaparavanda P Naren
Cedars-Sinai Medical Center, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- cystic fibrosis
- personalized medicine
- protein trafficking
- protein-protein interactions
- macromolecular complexes
- CFTR biology
-
Goutham Narla
University of Michigan, United States
- Expertise
- Medicine
- Cancer Biology
- Genetics and Genomics
- Research focus
- cancer therapeutics
- cancer genetics
- small molecule drug development
- protein phosphatase
- Experimental organism
- human
- mouse
-
P Darrell Neufer
East Carolina University, United States
- Expertise
- Biochemistry and Chemical Biology
- Cell Biology
- Medicine
- Research focus
- metabolic disease
- mitochondrial bioenergetics
- cellular bioenergetics
- mitochondrial biogenesis and exercise
- Experimental organism
- human
- flies
- rat
- mouse
-
Belinda Nicolau
McGill University, Canada
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer epidemiology
- social determinants of health
-
Ole Haagen Nielsen
Herlev Hospital, University of Copenhagen, Denmark
- Expertise
- Medicine
- Research focus
- gastroenterology (especially inflammatory bowel disease)
- internal medicine
-
Jeremie Nsengimana
Newcastle University, United Kingdom
- Expertise
- Medicine
- Research focus
- statistics
- genomics
- cancer
- precision medicine
- biomarkers
-
Izuchukwu Okafor
Nnamdi Azikiwe University, Nigeria
- Expertise
- Cancer Biology
- Cell Biology
- Chromosomes and Gene Expression
- Developmental Biology
- Epidemiology and Global Health
- Genetics and Genomics
- Medicine
- Neuroscience
- Research focus
- developmental biology
- reproductive biology
- gene expression
- molecular biology
- public health
- reproductive health
- medical education
- anatomical sciences
- neuroreproduction
-
Jihwan Park
Gwangju Institute of Science and Technology, South Korea
- Expertise
- Computational and Systems Biology
- Medicine
- Research focus
- single cell analysis
- kidney disease
-
Renata Pasqualini
Rutgers University, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- radiation oncology
- translational cancer research
- prostate cancer
- vascular biology
-
Gang Peng
Indiana University, United States
- Expertise
- Medicine
- Computational and Systems Biology
- Chromosomes and Gene Expression
- Research focus
- bioinformatics
- epigenetics
- sequencing
- DNA methylation
- Newborn Screening
-
Luca Pinello
Massachusetts General Hospital, United States
- Expertise
- Medicine
- Computational and Systems Biology
- Genetics and Genomics
- Research focus
- bioinformatics
- computational biology
- CRISPR genome editing
- single-cell genomics
-
Samuel Pleasure
University of California, San Francisco, United States
- Expertise
- Medicine
- Developmental Biology
- Neuroscience
- Research focus
- circuit development
- hippocampus
- cerebral cortex
- epilepsy
- human
- forebrain development
- autoimmune encephalitis
- morphogenic signals
- mouse
- multiple sclerosis
-
Markus Ploner
Technische Universität München, Germany
- Expertise
- Neuroscience
- Medicine
- Research focus
- pain
- brain
- oscillations
- synchrony
- electroencephalography (EEG)
- Experimental organism
- human
-
Serge Przedborski
Columbia University Medical Center, United States
- Expertise
- Neuroscience
- Medicine
- Research focus
- Parkinson's disease
- neurodegeneration
- mitochondrial damage
- motor neuron disease
- amyotrophic lateral sclerosis
- astrocytes
- autophagy
- mitophagy
- necroptosis
- apoptosis
- Experimental organism
- human
-
Matthew A Quinn
Wake Forest School of Medicine, United States
- Expertise
- Medicine
- Research focus
- translational liver disease
- obesity
- women's health
- fatty liver
- nuclear receptors
- reproduction
- epigenesis
-
Jalees Rehman
University of Illinois at Chicago, United States
- Expertise
- Cell Biology
- Genetics and Genomics
- Immunology and Inflammation
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- vascular biology
- macrophage biology
- inflammation
- transcriptomics
- single cell analysis
- lung biology
- cell regeneration
-
Martin Reincke
Ludwig-Maximilians-Universität München, Germany
- Expertise
- Medicine
- Research focus
- endocrinology
- metabolism
- endocrine hypertension
- adrenal gland function
- pituitary-adrenal-axis
- pituitary disease
- cortisol, stress research
- adrenomedullary function
-
Albert Rizvanov
Kazan Federal University, Russia
- Expertise
- Medicine
- Research focus
- stem cells
-
Isabel Rodriguez-Barraquer
University of California, San Francisco, United States
- Expertise
- Epidemiology and Global Health
- Microbiology and Infectious Disease
- Medicine
- Research focus
- dengue
- malaria
- Zika
- vector-borne diseases
- serology
- modeling
- Experimental organism
- human
-
Gian Paolo Rossi
University of Padua, Italy
- Expertise
- Medicine
- Research focus
- arterial hypertension
- vascular biology
- cardiology
- cardiovascular medicine
- endocrinology
- Experimental organism
- human
-
Maroeska M Rovers
Radboud University Nijmegen, Netherlands
- Expertise
- Medicine
- Research focus
- evidence-based surgery
- clinical epidemiology
- health economics
- IPD meta-analysis
-
Mishaela R Rubin
Columbia University Medical Center, United States
- Expertise
- Medicine
- Research focus
- diabetes
- parathyroid
- osteoporosis
-
Natalia Rubinstein
University of Buenos Aires-CONICET, Argentina
- Expertise
- Cancer Biology
- Immunology and Inflammation
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- breast cancer tumor cell
- molecular biology
- drug resistance
- tumor immunology
-
Vitaly Ryu
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Neuroscience
- Research focus
- pituitary hormones
- neurogenesis
- neural plasticity
- neurobehavior
- ingestive behavior
- sympathetic and sensory innervation of fat
-
Juan C Sáez
Universidad de Valparaíso, Chile
- Expertise
- Neuroscience
- Cell Biology
- Medicine
- Research focus
- connexin
- pannexin
- innexin
- neuroinflammation
- neuromuscular diseases
-
Fayez Safadi
Northeast Ohio Medical University, United States
- Expertise
- Medicine
- Stem Cells and Regenerative Medicine
- Research focus
- biomechanics
-
Tamer I Sallam
University of California, Los Angeles, United States
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- atherosclerosis
- lipid metabolism
- cardiovascular disease
- noncoding RNA
- gene regulation
-
Charles Sawyers
Memorial Sloan-Kettering Cancer Center, United States
- Expertise
- Cancer Biology
- Medicine
- Research focus
- translational medicine
- oncology
- Experimental organism
- human
-
Nicolas Schlecht
Roswell Park Comprehensive Cancer Center, United States
- Expertise
- Epidemiology and Global Health
- Medicine
- Research focus
- cancer prevention
- cancer control
-
Jawed Siddiqui
University of Nebraska Medical Center, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- bone metastasis
- cancer metastasis
- chemokines
- osteoclasts
- osteoblasts
- tumor dormancy
- therapeutic
-
Kumaravel Somasundaram
Indian Institute of Science Bangalore, India
- Expertise
- Cell Biology
- Medicine
- Cancer Biology
- Genetics and Genomics
- Chromosomes and Gene Expression
- Research focus
- cell signalling
- glioma
- gene regulation
- cancer therapeutics
- cancer genomics
- cancer stem cells
- non-coding RNA
- chemoresistance
-
Renan P Souza
Universidade Federal de Minas Gerais, Brazil
- Expertise
- Genetics and Genomics
- Medicine
- Research focus
- molecular epidemiology
- genomics
- biomarkers
- statistical modeling
- cohort studies
- case-control studies
- simulation studies
-
Jonathan S Stamler
Case Western Reserve University, United States
- Expertise
- Medicine
- Biochemistry and Chemical Biology
- Research focus
- S-nitrosylation
- nitric oxide
- redox
- redox-signaling
- cysteine
- thiols
-
Margaret Stanley
University of Cambridge, United Kingdom
- Expertise
- Cancer Biology
- Microbiology and Infectious Disease
- Medicine
- Epidemiology and Global Health
- Research focus
- vaccines
- cervix cancer
- cervix precancer
- keratinocyte biology
- human papillomavirus
- DNA viruses
- vaccine immunology
- Experimental organism
- human
-
Laurie Steiner
University of Rochester Medical Center, United States
- Expertise
- Medicine
- Cell Biology
- Chromosomes and Gene Expression
- Research focus
- transcription
- epigenetics
- erythropoiesis
- hematopoiesis
- histone modifications
- anemia
- Experimental organism
- human
- mouse
-
N. Ravi Sundaresan
Indian Institute of Science, India
- Expertise
- Cell Biology
- Medicine
- Biochemistry and Chemical Biology
- Chromosomes and Gene Expression
- Stem Cells and Regenerative Medicine
- Research focus
- reversable acetylation
- ADP-ribosylation
- cellular senescence and aging
- sirtuins
- cardiac and skeletal muscle diseases
- fibrosis
- Experimental organism
- human
- mouse
- rat
-
Kiyoshi Takeda
Osaka University, Japan
- Expertise
- Immunology and Inflammation
- Medicine
- Research focus
- mucosal immunology
- inflammatory bowel disease
- intestinal immunity
- intestinal environmental factors
- intestinal epithelial cells
-
Sakae Tanaka
The University of Tokyo, Japan
- Expertise
- Medicine
- Research focus
- bone
- osteoporosis
- osteoclast
- osteoarthritis
- rheumatoid arthritis
- orthopaedics
-
Mauro M Teixeira
Universidade Federal de Minas Gerais, Brazil
- Expertise
- Medicine
- Immunology and Inflammation
- Microbiology and Infectious Disease
- Research focus
- inflammation
- mediators of inflammation
- pharmacology
- anti-viral compounds
- arboviral infections
- clinical trials
-
Carmen D Tekwe
Indiana University Bloomington, United States
- Expertise
- Medicine
- Research focus
- biostatistics
- dietary intake
- physical activity behavior
-
Aseem Prakash Tikku
King George's Medical University, India
- Expertise
- Medicine
- Research focus
- dentistry
- endodontics
-
Peter Tontonoz
University of California, Los Angeles, United States
- Expertise
- Cell Biology
- Medicine
- Research focus
- lipid metabolism
- cholesterol
- nuclear receptors
- adipocytes
- obesity
- atherosclerosis
- diabetes
- Experimental organism
- mouse
-
Farah Usmani
United Nations Population Fund (UNFPA), United States
- Expertise
- Medicine
- Research focus
- health policy
- reproductive health
- reproductive rights
-
Amit Verma
Albert Einstein College of Medicine, United States
- Expertise
- Medicine
- Cancer Biology
- Research focus
- leukemia
- cancer stem cells
- myelodysplasia
- clonal hematopoiesis
-
Mei Wan
Johns Hopkins University School of Medicine, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- bone remodeling
- osteoarthritis
- osteoblasts
- osteoclast
- cellular senescence
- mesenchymal stem cells
- progenitor cells
-
Tracey L Weissgerber
Berlin Institute of Health (BIH) at Charité, Germany
- Expertise
- Medicine
- Research focus
- data visualization
- statistical analysis
- reproducibility
- meta-research
- open and reproducible methods
- systematic review
- scientific rigor
- transparency
- automated screening
-
Christopher S Williams
Vanderbilt University, United States
- Expertise
- Medicine
- Research focus
- gastroenterology
- GI track cancer
- murine
- inflammatory bowel disease
-
Yongliang Yang
Dalian University of Technology, China
- Expertise
- Medicine
- Cancer Biology
- Computational and Systems Biology
- Research focus
- bioinformatics
- computational biology
- drug discovery
- artificial intelligence
-
Yunlei Yang
Albert Einstein College of Medicine, United States
- Expertise
- Medicine
- Neuroscience
- Research focus
- glia
- neural circuits
- anxiety
- diabetes
- obesity
- neuron
-
Keqiang Ye
Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, China
- Expertise
- Medicine
- Cancer Biology
- Biochemistry and Chemical Biology
- Neuroscience
- Research focus
- neuroscience
- molecular cytobiology
- cancer biology
- neurodegenerative disease
- Experimental organism
- mouse
-
Neeha Zaidi
Johns Hopkins University, United States
- Expertise
- Cancer Biology
- Immunology and Inflammation
- Medicine
- Research focus
- immunology
- immunotherapy
- vaccines
- cancer
- cancer immunology
- clinical trials
- translational research
- T cell biology
-
Samir Zaidi
Memorial Sloan Kettering Cancer Center, United States
- Expertise
- Cancer Biology
- Computational and Systems Biology
- Medicine
- Research focus
- genetically engineered mouse models
- computational genomics
- single cell genomics
- organoids
- drug resistance
- cancer cell plasticity
-
Mark L Zeidel
Beth Israel Deaconess Medical Center, United States
- Expertise
- Medicine
- Research focus
- kidney disease
- bladder disease
-
Anja Zeigerer
Helmholtz Zentrum München, Germany
- Expertise
- Cell Biology
- Medicine
- Research focus
- type 2 diabetes
- membrane trafficking
- mitochondria
- cellular and systemic metabolism
- liver physiology
- MASLD
- endo-lysosomal system
-
Baohong Zhao
Hospital for Special Surgery, United States
- Expertise
- Medicine
- Cell Biology
- Research focus
- osteoclast
- osteoimmunology
- bone
- TNF
- Experimental organism
- mouse
-
Siming Zhao
Dartmouth College, United States
- Expertise
- Medicine
- Computational and Systems Biology
- Genetics and Genomics
- Research focus
- statistical genetics
- genomics
- human genetics
- sequencing data
-
Shengtao Zhou
Sichuan University West China Second University Hospital, China
- Expertise
- Cancer Biology
- Medicine
- Research focus
- gynecologic oncology
- cancer biology
- tumor immunology
- metabolism
- nuclear receptors
- systems biology
- Experimental organism
- human
- mouse
-
Weibin Zhou
Icahn School of Medicine at Mount Sinai, United States
- Expertise
- Medicine
- Research focus
- disease models
- kidney
- transgenic
- Experimental organism
- zebrafish
-
Hao Zhu
University of Texas Southwestern Medical Center, United States
- Expertise
- Cancer Biology
- Stem Cells and Regenerative Medicine
- Medicine
- Research focus
- mechanisms of tissue repair and organ regeneration
- liver cancer
- hepatocellular carcinoma
- epigenetics
- polyploidy
- Experimental organism
- human
- mouse
-
Bian Zhuan
Wuhan University, China
- Expertise
- Medicine
- Genetics and Genomics
- Research focus
- craniofacial genetics
- oral and craniofacial developmental defects
- orofacial clefts
- tooth agenesis
-
Roger S Zoh
Indiana University Bloomington, United States
- Expertise
- Medicine
- Research focus
- Bayesian statistical methods
-
Moussa Zouache
University of Utah, United States
- Expertise
- Computational and Systems Biology
- Medicine
- Epidemiology and Global Health
- Genetics and Genomics
- Neuroscience
- Physics of Living Systems
- Research focus
- visual neuroscience
- population genetics
- transcriptomics
- proteomics
- biology of aging
- mathematical modelling
- clinical research